http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001199889-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02 |
| filingDate | 2000-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280766f6460e6696f81a42db13d81d61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19cfc7c8e9b2ae82c43e87a948cc5f46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a030f7f7896184f17647cc83283775f6 |
| publicationDate | 2001-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2001199889-A |
| titleOfInvention | Nasal preparation containing condensed pyridazine derivative |
| abstract | (57) [Summary] [Problem] To provide an agent for nasal drops exhibiting excellent preventive and therapeutic effects on allergic rhinitis and the like. SOLUTION: The formula: [Wherein, Ar 1 and Ar 2 each represent an aromatic group; Ar 1 and Ar 2 may form a condensed ring group together with adjacent carbon atoms; ring B represents a nitrogen-containing heterocyclic ring; Y is a bond, an oxygen atom, S (O) p (p is 0 to 2), NR 4 (R 4 Represents H or a lower alkyl group) or a divalent linear lower hydrocarbon group optionally having 1 to 3 hetero atoms, and A represents N or CR 7 (R 7 represents H, a halogen atom, a hydrocarbon R 1 , R 2 and R 3 are H, a halogen atom, It represents a hydrocarbon group, an acyl group or a hydroxy group which may have a substituent, and R 8 represents H, a hydroxy group or a carboxyl group which may be substituted with a lower alkyl group. However, the nitrogen-containing heterocyclic ring represented by the ring B is represented by the formula: (N is not a heterocycle represented by 0 to 1). Or a salt thereof or a prodrug thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4689959-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03018020-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005511642-A |
| priorityDate | 1999-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 757.